Trusted with specialist, regulated and high-impact multilingual content




Translation is Only One Part of the Challenge
Life Sciences content rarely sits within one team or one moment in the product lifecycle. It moves
between clinical, regulatory, quality, product, marketing and regional stakeholders, often across
several systems, languages and review cycles.
When multilingual content grows, complexity grows with it
What begins as a single translation request can quickly become a wider operational challenge: keeping every language aligned, controlling terminology, managing updates, coordinating local review and deciding where human expertise or AI-supported workflows are appropriate.
ALM helps organisations turn this complexity into a structured, scalable multilingual process.
Built for regulated and specialist content
- Specialist Linguists matched to the subject matter and audience
- Translation memories and terminology systems for consistency
- Quality-controlled workflows based on content risk
- Support for clinical, regulatory, technical and commercial content
- Technology used to improve efficiency, not replace accountability
How Can We Support Your Life Sciences Content?
One Multilingual Partner Across
the Content Lifecycle
ALM can support isolated projects, but the strongest value often comes from building a repeatable
process that connects terminology, people and technology over time.
Specialist Experience that Goes
Beyond the First Project
ALM’s strongest partnerships grow because the service adapts with the client’s products, markets, teams and content requirements.
Different Teams. Different Pressures.
One Connected Process.
ALM’s role is not simply to translate text, but to help each stakeholder get the accuracy, consistency
and speed they need without creating additional coordination.
Frequently Asked Questions About Life Sciences Translation
ALM supports pharmaceutical, clinical research, medical device, MedTech and biotech organisations with multilingual content across the product lifecycle. This includes clinical trial materials, regulatory submissions, patient information, IFUs, labelling, technical documentation, software, training and commercial content.
The workflow, specialist expertise and level of review can be adapted according to the content, audience and associated risk.
Look beyond linguistic ability alone. A Life Sciences translation provider should be able to demonstrate relevant subject-matter expertise, defined quality processes, terminology management, appropriate technology, information security and experience with regulated multilingual content.
ALM combines specialist linguists with controlled workflows, translation memory, terminology management and defined quality assurance. Our translation processes are certified to ISO 17100 and our quality management system to ISO 9001.
ALM uses a risk-based approach rather than applying the same workflow to every document. We consider the content, audience, intended use and potential consequences of an error when determining the appropriate translation and review process.
Higher-risk, regulated, patient-facing or safety-critical content can be routed through more controlled workflows, including full specialist human review where appropriate.
ALM uses translation memory, terminology management, quality assurance technology, automation and, where appropriate, AI-assisted or machine translation workflows.
Technology is selected according to the content and its risk profile rather than applying one approach to every project. This allows existing approved translations and terminology to be reused while maintaining appropriate specialist human oversight. You can view details of our Language Operations Suite.
Yes, for appropriate content, but suitability should be assessed before deciding on the workflow.
ALM can screen content based on factors such as intended use, audience, regulatory and safety implications, confidentiality, language combination and the potential consequences of an error. This helps determine whether AI-assisted or machine translation is appropriate and what level of specialist human editing, review or full review is required.
For higher-risk content, specialist human translation or full specialist review may be the more appropriate approach.
Yes. ALM supports multilingual regulatory and controlled documentation, including regulatory submission content and associated clinical, medical and technical documentation.
Terminology management, specialist linguists and defined review processes can be used to help maintain consistency and document integrity across languages and successive updates.
ALM is Cyber Essentials accredited and applies defined security and confidentiality controls to client content. Where AI-assisted technology is appropriate, it is used within controlled workflows rather than placing confidential client content into uncontrolled public AI tools.
Client content is not used as public AI training data, and workflow requirements can be agreed according to the sensitivity and intended use of the material.


